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A B S T R A C T
Maternal micronutrient deﬁciencies in pregnancy can have profound eﬀects on fetal development and pregnancy
outcome. Plasma trace minerals including copper, zinc, selenium and iron have been shown to be extremely
important in supporting reproduction. We sought to determine whether there is an association between maternal
trace mineral status in early pregnancy and pregnancy complications using a prospective cohort study of 1065
pregnant Australian women who were recruited as part of the Screening for Pregnancy Endpoints (SCOPE) study
in Adelaide. Copper, zinc, selenium and iron present in the plasma were measured using mass spectrometry in
samples collected at 15 ± 1 weeks’ gestation. After adjusting for covariates, women with lower plasma copper
(< 27.9 μmol/L and 27.9–32.5 μmol/L) had decreased risk for any pregnancy complication when compared
with women with high plasma copper (> 32.5 μmol/L) (aRR = 0.87; 95% CI = 0.76, 0.99 and aRR = 0.88;
95% CI = 0.78, 1.00, respectively). This was also observed when adjusting for plasma zinc and selenium status
(< 27.9 μmol/L: aRR = 0.81; 95% CI = 0.69, 0.96 and 27.9–32.5 μmol/L: aRR = 0.84; 95% CI = 0.72, 0.98).
Combined low copper and zinc status was also associated with a reduced risk of any pregnancy complication as
compared with high copper and zinc status (aRR = 0.80; 95% CI = 0.70, 0.93). These results provide justiﬁ-
cation for further work into elucidating the mechanistic role of trace elements in early pregnancy, as well as their
interactions in supporting successful pregnancy outcomes.
Maternal nutrient stores and diet supply all the macro- and micro-
nutrients to support optimal fetal growth essential for successful preg-
nancy [1]. Hence, it is not surprising that maternal deﬁciencies in key
micronutrients can have profound eﬀects on fetal development and
pregnancy outcome [2]. Pregnancy complications including pre-
eclampsia (PE), gestational diabetes mellitus (GDM), spontaneous pre-
term birth (sPTB) and fetal growth restriction (FGR) together aﬀect
25% of ﬁrst pregnancies and predict lifelong morbidity and mortality
for both the mother and infant [3]. Furthermore, micronutrient deﬁ-
ciencies which tend to be associated with decreased consumption of
foods rich in micronutrients, have also been associated with the de-
velopment of PE, GDM, sPTB, FGR, as well as gestational hypertension
(GH) [2].
Extensive investigations into micronutrient deﬁciencies have fo-
cused on those common within pregnant populations including folate
and vitamin D [4]. However, evidence is emerging about the im-
portance of trace minerals like iron, zinc and copper in supporting
successful pregnancy [5]. It is known that trace minerals are crucial for
the maintenance of cell proliferation and function with severe deﬁ-
ciencies in copper and zinc during pregnancy having been shown to
have a teratogenic eﬀect on the fetus [6]. This is likely driven by a
reduction in the activity of key enzymes which require these metals
structurally in order to function, as well as compromised oxidant de-
fence systems [6]. It is also important to acknowledge the importance of
micronutrients in mediating inﬂammation and the immune response.
Animal models of iron, copper and zinc deﬁciencies have been shown to
be associated with compromised immunity and increased susceptibility
to infection [7]. Pregnancy complications including PE and FGR have
been associated with increased oxidative stress and circulating markers
of inﬂammation [8,9] and therefore there may be a causal connection
https://doi.org/10.1016/j.jtemb.2017.11.016
Received 18 September 2017; Received in revised form 20 November 2017; Accepted 30 November 2017
⁎ Corresponding author at: Adelaide Medical School University of Adelaide Adelaide, SA, 5005, Australia.
E-mail address: claire.roberts@adelaide.edu.au (C.T. Roberts).
Abbreviations: FGR, fetal growth restriction; GDM, gestational diabetes mellitus; GH, gestational hypertension; PE, preeclampsia; sPTB, spontaneous preterm birth; SGA, small-for-
gestational age
Journal of Trace Elements in Medicine and Biology 46 (2018) 103–109
0946-672X/ Crown Copyright © 2017 Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/BY-NC-ND/4.0/).
T
between micronutrient deﬁciencies in pregnancy and the development
of pregnancy complications mediated by oxidative stress and in-
ﬂammation.
The association between trace minerals and pregnancy have been
described previously [10–17], however many of these studies have been
conducted in late pregnancy or at term. Given that many of these
pregnancy complications originate in early gestation, it is important to
also understand how micronutrient status in the ﬁrst trimester is as-
sociated with adverse pregnancy outcomes. Marginal micronutrient
deﬁciencies early in pregnancy may lead to more severe deﬁciencies
later in pregnancy due to increased metabolic demands from the rapidly
growing placenta and fetus. Thus we aimed to determine whether de-
ﬁciencies in the trace minerals copper, zinc, selenium and iron at
15 ± 1 weeks’ gestation may be associated with a number of preg-
nancy complications. As copper and zinc share similar electro-chemical
properties and biological pathways [18], we also explored interactions
between zinc and copper status in early pregnancy and their relation-
ship with adverse pregnancy outcomes with the goal of better under-
standing how these minerals may be important to successful pregnancy.
1. Materials and methods
1.1. Study participants
Plasma samples were obtained from Adelaide participants recruited
as part of the international prospective Screening for Pregnancy
Endpoints (SCOPE) study. Nulliparous women carrying a singleton
pregnancy were recruited at 15 ± 1 weeks’ gestation from the Lyell
McEwin Hospital, Adelaide, Australia between November 2004 and
September 2008. Ethics approval was gained from the University of
Adelaide ethics committee and all women provided written consent
(approval no: REC 1712/5/2008). At recruitment, women were inter-
viewed by a research midwife and asked questions on maternal de-
mographics and had physical measurements recorded. These included
age, body mass index (BMI) and smoking status [19]. Biochemical
markers were also measured at 15 ± 1 weeks’ gestation and included
plasma C-reactive protein (CRP) [20]. Women were not eligible to
participate in the study if they suﬀered from a pre-existing medical
condition or had obstetric history which placed them at high risk of
developing PE, sPTB or delivering a small-for-gestational age (SGA)
infant. Those who had suﬀered three or more miscarriages or had un-
dergone three or more pregnancy terminations were also excluded.
Uncomplicated pregnancies were deﬁned as those without any
pregnancy disorder and included normotensive women who delivered
an appropriate weight for gestational age infant at term (≥37 weeks’
gestation) [21]. GH was diagnosed as the development of high blood
pressure (systolic blood press ≥140 mmHg and/or diastolic blood
pressure ≥90 mmHg) on at least two occasions after 20 weeks’ gesta-
tion. PE was deﬁned as GH in conjunction with proteinuria (24 h ur-
inary protein ≥300 mg or a spot urine protein:creatinine ratio
≥30 mg/mmol creatinine or urine dipstick protein ≥2) or any multi-
system complication of PE or uteroplacental dysfunction [22]. GDM
was diagnosed according to the International Associations of Diabetes
and Pregnancy Study Groups criteria [23]. sPTB was deﬁned as the
spontaneous onset of labour at< 37 weeks’ gestation. SGA was deﬁned
as birth weight below the 10th customised centile adjusted for maternal
height, booking weight, ethnicity, delivery gestation and infant sex.
1.2. Elemental analysis
Venous blood samples were provided at 15 ± 1 weeks’ gestation
and collected into heparinised tubes in order to obtain plasma samples
and then analysed using inductively-coupled plasma mass spectrometry
(ICP-MS) (Agilent 7700 ICP-MS) (Agilent 5100 ICP-OES; CSIRO
Analytical Services, South Australia) to measure the concentrations of
copper, selenium, iron and zinc. Prior to analysis, 250 μL of plasma was
digested in concentrated nitric acid (0% HNO3) in sealed Teﬂon con-
tainers for approximately 48 h and then diluted. Samples were run
alongside two internal standards: iridium and rhodium (Choice
Analytical) at a concentration of 200 ppb and an 8-point calibration,
including blank, was carried out between 0.01 μg/L and 100 μg/L.
There were 47 (4.4%) women with plasma iron levels below the de-
tection limit of 7.16 μmol/L and were therefore assigned 7.15 μmol/L.
1.3. Statistical analysis
All statistical analysis was performed in R (v3.1.1) [24]. Baseline
characteristics were tested for normality using the Shapiro-Wilk test
and summarised according to pregnancy outcome. Fisher’s exact tests
were performed for categorical variables and Welch’s t test for con-
tinuous variables comparing women with each pregnancy complication
to all other women. Plasma copper, zinc, selenium and iron were ex-
pressed as mean (± standard deviation: SD) and compared between
women who developed a pregnancy complication and those who did
not using a non-parametric Mann-Whitney U. Spearman’s correlations
were used to examine the relationship between each of the trace mi-
nerals with each other, as well as with circulating CRP; a marker of
inﬂammation.
In order to assess the eﬀects of each trace mineral on pregnancy
outcome, plasma copper, zinc, selenium and iron were divided into
tertiles based on their distribution amongst all women in this study.
Relative risks (RR) and 95% conﬁdence intervals (CIs) of pregnancy
complications from any complication, PE, GH, GDM, sPTB and SGA for
copper, zinc, selenium and iron were examined using multivariable
Poisson regression with robust variance estimation. Multivariable ad-
justment was made for maternal age, maternal BMI and smoking status
at 15 ± 1 weeks’ gestation (yes compared to no) as covariates.
Maternal socioeconomic status, determined by assigning the New
Zealand socioeconomic index score (SEI) [25], was initially included in
the adjusted model but did not change any eﬀects observed and was
subsequently removed in the ﬁnal analyses. The ﬁnal analyses were also
repeated for copper, zinc and selenium adjusting for each other as well
as covariates previously mentioned.
2. Results
Of the 1165 SCOPE women recruited in Adelaide, 1065 (91%)
plasma samples from 15 ± 1 weeks’ gestation were available for
analysis of trace minerals. These included 558 (52%) women whose
pregnancies were uncomplicated, 85 (8%) who later developed PE, 108
(10%) who were diagnosed with GH, 51 (5%) who were diagnosed with
GDM, 65 (6%) who delivered spontaneously preterm and 134 (13%)
who delivered an SGA infant. Mean maternal age and BMI for all
women whose plasma was analysed was 23.71 ± 5 years and
27.01 ± 6.52 kg/m2 (Table 1). Compared to those whose pregnancies
were uncomplicated, women who went on to have a pregnancy com-
plication had a higher BMI in early pregnancy but there was no dif-
ference in maternal age, smoking status or use of supplements at
15 ± 1 weeks’ gestation.
Plasma trace minerals in all women ranged from 10.3 to
52.99 μmol/L for copper, 3.24–34.70 μmol/L for zinc,
0.253–1.785 μmol/L for selenium and 7.14–72.60 μg/L for iron. Mean
plasma copper at 15 ± 1 weeks’ gestation was higher in women who
went onto have a pregnancy complication when compared to those
whose pregnancies remained uncomplicated (Table 1; P < 0.001).
Moderate diﬀerences in circulating levels of zinc, selenium and iron
were also observed in the women who later developed a pregnancy
complication compared to those who did not (Table 1). Circulating
copper was positively correlated with both zinc (Supplementary
Fig. 1A; R2 = 0.263) and selenium (Supplementary Fig. 1B;
R2 = 0.303) but negatively correlated with iron (Supplementary
Fig. 1C; R2 =−0.156). Iron on the other hand, was positively
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correlated with zinc (Supplementary Fig. 1E; R2 = 0.107) and selenium
(Supplementary Fig. 1F; R2 = 0.204).
A signiﬁcant positive correlation between plasma copper and
plasma CRP was observed at 15 ± 1 weeks’ gestation (Fig.1A :
R2 = 0.424, P < 0.001) while there was an inverse, albeit not as
strong, correlation between plasma zinc and plasma iron and CRP
(Fig. 1B: R2 =−0.066, P = 0.048 and Fig. 1D: R2 =−0.280,
P < 0.001, respectively). When BMI was categorised as underweight
(≤20 kg/m2), normal weight (20.1–24.9 kg/m2), overweight
(25–29.9 kg/m2) and obese (≥30 kg/m2), compared with normal
weight women, plasma zinc, selenium and iron was lower in the obese
women (Fig. 2). Plasma copper on the other hand was signiﬁcantly
higher in the obese women when compared to underweight, normal
weight and overweight women (Fig. 2).
The adjusted relative risks (aRR) for each pregnancy complication
of plasma copper, zinc, selenium and iron categories based on popu-
lation tertiles are shown in Table 2. Women with lower plasma copper
(1 st and 2nd tertile) had decreased risk for any pregnancy complication
Table 1
Participant characteristics of the Adelaide SCOPE cohort in which plasma trace minerals were measured at 15 ± 1 weeks’ gestation.
All (n= 1065) Uncomplicated (n= 558) Complicated (n= 507) P value
Age yrs, mean (SD) 23.71 (5) 23.59 (5) 23.85 (5) 0.399
(range) [14–43] [14–40] [15–43]
BMI kg/m2, mean (SD) 27.01 (6.52) 26.30 (5.86) 27.77 (7.12) 0.000
(range) [16.2–58.5] [16.2–49.7] [16.4–58.5]
Smoking status, n (%) 0.063
No 651 (61) 352 (54) 299 (46)
Quit 152 (14) 85 (56) 67 (47)
Smoking 262 (25) 121 (46) 141 (54)
Education, n (%) 0.410
No Secondary 422 (40) 211 (50) 211 (50)
Secondary 608 (57) 327 (54) 381 (46)
Tertiary 35 (3) 20 (57) 15 (43)
Supplement Use, n (%) 0.535
No 105 (10) 51 (49) 53 (51)
Yes 960 (90) 506 (53) 454 (47)
Plasma Cu μmol/L, mean (SD) 30.30 (5.49) 29.61 (5.18) 31.07 (5.72) 0.000
[range] [10.30–52.99] [14.76–47.73] 52.99
Plasma Zn μmol/L, mean (SD) 9.39 (2.32) 9.28 (2.11) 9.51 (2.52) 0.077
[range] [3.24–34.70] [4.83–21.36] 34.70
Plasma Se μmol/L, mean (SD) 0.919 (0.151) 0.911 (0.140) 0.929 (0.161) 0.055
[range] [0.253–1.785] [0.544–1.380] [0.253–1.785]
Plasma Fe μmol/L, mean (SD) 19.06 (7.77) 19.49 (7.90) 18.61 (7.61) 0.053
[range] [7.14–72.60] [7.14–71.06] [7.14–72.60]
Supplement use was deﬁned as using any form of mineral or vitamin supplement at 15 ± 1 weeks’ gestation.
P values for continuous variables were determined using Welch t-test, categorical variables a Fisher’s exact test and plasma trace elements a Mann-Witney U test comparing women with a
pregnancy complication to those whose pregnancies remained uncomplicated. BMI: body mass index; Cu: Copper; Zn: Zinc; Se: Selenium; Fe: Iron.
Fig. 1. Spearman’s correlations between plasma
trace minerals at 15 ± 1 weeks’ gestation and serum
CRP at 15 ± 1 weeks’ gestation. A signiﬁcant posi-
tive correlation was seen between plasma copper and
CRP (A), whilst signiﬁcant negative correlations were
observed between plasma zinc (B) and plasma iron
(D) with CRP. No correlation was found between
plasma selenium and CRP (C).
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combined compared with women with high plasma copper (3rd tertile)
(aRR = 0.77; 95% CI = 0.66, 0.91 and aRR = 0.81; 95% CI = 0.70,
0.95, respectively). When the pregnancy complications were separated,
the protective eﬀect of low plasma copper was seen in all complications
except GH however, these associations were not statistically signiﬁcant.
Women with lower plasma zinc and selenium (1 st tertile) also had
decreased risk of any pregnancy complication when compared to high
plasma zinc and plasma selenium (aRR = 0.86; 95% CI = 0.74, 1.00
and aRR: 0.84; 95% CI = 0.73, 0.96, respectively). Given that the
strongest eﬀect was observed with plasma copper, we sought to assess
whether an association between plasma copper status at 15 ± 1 weeks’
gestation was still observed after adjust for plasma zinc and plasma
selenium (Supplementary Table 1). A signiﬁcant decreased risk for any
complication was observed in women within the ﬁrst and second tertile
of plasma copper when compared to women in the third tertile in-
dicating a relationship independent of plasma zinc or selenium status
(aRR = 0.81; 95% CI = 0.69, 0.61 and aRR = 0.84; 95% CI = 0.72,
0.98, respectively). There was no signiﬁcant eﬀect of maternal iron
status in early pregnancy on developing any pregnancy complication.
However, women with plasma iron in the 1 st and 2nd tertile were at
increased risk of GH when compared to women in the 3rd tertile
(aRR = 1.78; 95% CI = 1.05, 3.02 and aRR = 1.87; 95% CI = 1.12,
3.11, respectively).
A sensitivity analysis was performed between plasma copper and
CRP in order to determine the relationship between copper, in-
ﬂammation and pregnancy outcome. Serum CRP measured at 15 ± 1
weeks’ gestation was used as an indirect marker of inﬂammation.
Women with CRP ≥20.3 ng/mL were excluded as normal circulating
CRP ranges between 0.4–20.3 ng/mL [26] and levels higher than
20 ng/mL are often associated with infection. Supplementary Table 2
shows the eﬀects of plasma copper status in all (n= 1065) women as
well as those with CRP<20.3 ng/mL (n= 717). The point estimates
for the eﬀects for lower plasma copper in the women whose CRP
was< 20.3 ng/mL was similar to those for all women (1 st tertile: all
women = 0.77 vs. women with CRP<20.3 ng/mL = 0.74 & 2nd ter-
tile: all women = 0.81 vs. women with CRP<20.3 ng/mL = 0.78)
indicating the possibility that the eﬀects of plasma copper status in this
study is likely to be independent of inﬂammation.
Given that copper and zinc share similar electro-chemical properties
and biological pathways [18], the interactions between these two trace
minerals was analysed in relation to pregnancy complications (Table 3).
Combined low zinc status (1 st tertile) and low copper status (1 st ter-
tile) was associated with a reduced risk of any pregnancy complication
compared with high zinc status and high copper status (2nd and 3rd
tertile combined for both trace minerals) (aRR = 0.72; 95% CI = 0.62,
0.85). Similarly, combined low copper and high zinc was also asso-
ciated with reduced risk of any pregnancy complication when com-
pared to combined high zinc and high copper (aRR = 0.76; 95%
CI = 0.62, 0.94) suggesting copper status is a more important de-
terminant of pregnancy outcome. When each pregnancy complication
was analysed separately, a similar protective eﬀect of combined low
copper and low zinc was seen in PE, GDM, sPTB and SGA. For SGA, this
was statistically signiﬁcant (aRR = 0.62; 95% CI = 0.41, 0.94). For
GDM, combined low copper and high zinc, as well as high copper and
low zinc, also appeared to increase risk when compared to combined
high copper and high zinc although these were not statistically sig-
niﬁcant (aRR = 1.46; 95% CI = 0.57, 3.69 and RR = 1.78; 95%
CI = 0.77, 4.10, respectively).
Fig. 2. Relationship between plasma trace minerals at 15 ± 1 weeks’ gestation and maternal body mass index (BMI). Compared with normal weight (BMI 20.1–24.9) women, plasma
copper was lower in lean (BMI≤ 20) women, higher in obese (BMI≥ 30) and no diﬀerent in overweight (BMI 25–29.9) (A). Plasma zinc (B), plasma selenium (C) and plasma iron also
did not change between normal weight and overweight women, however, were signiﬁcantly lower in the obese women when compared to normal weight women. Box plots represent
median: 10th–90th centile. Groups compared using a Dunn’s test with a Bonferroni post-hoc test.
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3. Discussion
In this study, we have comprehensively assessed plasma trace mi-
nerals in early pregnancy and their association with multiple pregnancy
complications. Contrary to previous observations of the negative im-
pacts of poor trace element status on pregnancy outcome, we observed
a protective eﬀect of lower levels of plasma copper, zinc and selenium
at the beginning of pregnancy on the risk of any pregnancy complica-
tion. However, this relationship is highly likely to be driven by copper
status rather than zinc or selenium as plasma copper was found to be
associated with adverse pregnancy outcome after adjusting for plasma
zinc and selenium. This provides justiﬁcation for further work into
elucidating the role of copper in pregnancy, and the interaction with
other trace elements, particularly plasma zinc, in early pregnancy.
Trace elements like copper, zinc and selenium are integral to sup-
porting cellular and tissue physiology [27]. Indeed, animal models of
copper, zinc and selenium deﬁciency in pregnancy consistently show
negative eﬀects on fertility, fetal growth and oﬀspring health and
wellbeing [28–32]. Copper status in pregnancy has been infrequently
reported in the literature and has focused predominantly on copper
deﬁciency as adequate supply of copper during pregnancy is necessary
for early embryonic development [33]. Circulating levels of copper
increase during pregnancy due to the increase in copper-carrying pro-
teins in the blood mediated by estrogen [34,35]. Furthermore, in this
Table 2
Adjusted relative risks of pregnancy complications from all complications, preeclampsia (PE), gestational hypertension (GH), gestational diabetes mellitus (GDM), spontaeous preterm
birth (sPTB) and small-for-gestational age (SGA) according to plasma levels of trace minerals categorised based on population tertiles.
Pregnancy Complication
All women Any Complications PE GH GDM sPTB SGA
n n (%) aRR* (95%
CI)
n (%) aRR* (95%
CI)
n (%) aRR* (95%
CI)
n (%) aRR* (95%
CI)
n (%) aRR* (95%
CI)
n (%) aRR* (95%
CI)
Copper
< 27.9 μmol/L 360 150 (42) 0.77 (0.66,
0.91)
21 (6) 0.71 (0.42,
1.18)
33 (9) 1.11 (0.71,
1.75)
13 (4) 0.69 (0.35,
1.37)
20 (6) 0.62 (0.34,
1.15)
34 (9) 0.66 (0.44,
1.00)
27.9 −32.5 μmol/L 349 156 (45) 0.81 (0.70,
0.95)
27 (8) 0.88 (0.55,
1.42)
36 (10) 1.16 (0.75,
1.80)
13 (4) 0.66 (0.33,
1.32)
16 (5) 0.52 (0.28,
0.98)
49 (14) 0.95 (0.66,
1.38)
> 32.5 μmol/L 356 201 (56) 1.0† 37 (10) 1.0† 39 (11) 1.0† 25 (7) 1.0† 29 (8) 1.0† 51 (14) 1.0†
Zinc
< 8.3 μmol/L 357 160 (45) 0.86 (0.74,
1.00)
26 (7) 0.80 (0.48,
1.32)
42 (12) 1.01 (0.66,
1.56)
15 (4) 0.82 (0.43,
1.55)
15 (4) 0.85 (0.47,
1.52)
42 (12) 0.75 (0.52,
1.08)
8.3–9.9 μmol/L 351 165 (47) 0.91 (0.78,
1.06)
29 (8) 0.91 (0.56,
1.47)
32 (9) 0.91 (0.58,
1.43)
14 (4) 0.97 (0.50,
1.88)
27 (8) 0.91 (0.51,
1.60)
36 (10) 0.65 (0.44,
0.96)
>9.9 μmol/L 356 182 (51) 1.0† 30 (8) 1.0† 34 (10) 1.0† 22 (6) 1.0† 23 (6) 1.0† 56 (16) 1.0†
Selenium
<0.86 μmol/L 449 203 (45) 0.84 (0.73,
0.96)
33 (7) 0.72 (0.45,
1.18)
49 (11) 0.94 (0.62,
1.42)
19 (4) 1.08 (0.55,
2.15)
25 (6) 0.76 (0.44,
1.31)
49 (11) 0.81 (0.55,
1.19)
0.86-0.96 μmol/L 199 83 (42) 0.80 (0.66,
0.96)
15 (8) 0.82 (0.45,
1.48)
16 (8) 0.77 (0.44,
1.35)
11 (6) 1.71 (0.78,
3.77)
9 (5) 0.62 (0.29,
1.33)
25 (13) 0.96 (0.61,
1.50)
> 0.96 μmol/L 417 221 (53) 1.0† 37 (9) 1.0† 43 (10) 1.0† 21 (5) 1.0† 31 (7) 1.0† 60 (14) 1.0†
Iron
< 15.64 μmol/L 356 180 (51) 1.08 (0.92,
1.27)
31 (9) 0.81 (0.49,
1.35)
47 (13) 1.78 (1.05,
3.02)
19 (5) 1.16 (0.53,
2.56)
24 (7) 1.11 (0.60,
2.03)
45 (13) 1.22 (0.81,
1.83)
15.6–21.2 μmol/L 353 171 (48) 1.08 (0.92,
1.26)
26 (7) 0.87 (0.52,
1.46)
40 (11) 1.87 (1.12,
3.11)
20 (6) 1.46 (0.74,
2.89)
18 (5) 0.78 (0.43,
1.43)
52 (15) 1.36 (0.92,
2.01)
> 21.2 μmol/L 355 155 (44) 1.0† 28 (8) 1.0† 20 (6) 1.0† 12 (3) 1.0† 23 (6) 1.0† 37 (10) 1.0†
*Adjusted relative risks were adjusted for age, maternal body mass index and smoking status at 15 ± 1 weeks' gestation (no versus yes).
†Reference category.
Table 3
Adjusted relative risks (aRR) of pregnancy complications from all complications, preeclampsia (PE), gestational hypertension (GH), gestational diabetes mellitus (GDM), spontaeous
preterm birth (sPTB) and small-for-gestational age (SGA) based on stratiﬁcation by combined plasma copper and plasma zinc concentrations.
Pregnancy complication
All women Any Complications PE GH GDM sPTB SGA
n n (%) aRR* (95%
CI)
n (%) aRR* (95%
CI)
n (%) aRR* (95%
CI)
n (%) aRR* (95%
CI)
n (%) aRR* (95%
CI)




519 222 (43) 0.72 (0.62,
0.85)
36 (7) 0.67 (0.39,
1.16)
55 (11) 0.94 (0.57,
1.55)
17 (3) 0.71 (0.31,
1.61)
27 (5) 0.55 (0.30,
1.01)




192 85 (44) 0.76 (0.62,
0.94)
13 (7) 0.75 (0.37,
1.51)
14 (7) 0.67 (0.34,
1.34)
9 (5) 1.46 (0.57,
3.69)
9 (5) 0.49 (0.21,
1.12)




197 105 (53) 0.86 (0.72,
1.03)
19 (10) 0.87 (0.47,
1.61)
20 (10) 0.86 (0.47,
1.56)
17 (9) 1.78 (0.77,
4.10)
14 (7) 0.75 (0.37,
1.50)




156 95 (61) 1.0† 17 (11) 1.0† 19 (12) 1.0† 8 (5) 1.0† 15 (10) 1.0† 28 (18) 1.0†
Low Copper≤32.5 μmol/L (1 st and 2nd tertile combined), High Copper>32.5 μmol/L (3rd tertile), Low Zinc≤9.91 μmol/L (1 st and 2nd tertile combined), High Zinc> 9.91 μmol/L
(3rd tertile)
* Adjusted relative risks were adjusted for age, maternal body mass index and smoking status at 15 ± 1 weeks’ gestation (no versus yes).
† Reference category.
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population, circulating plasma copper was similar to pregnancy re-
ference ranges (10–90th centile: 26.4–33.8 μmol/L) and to those re-
ported in other populations of pregnant women [26,34,36–38]. Thus,
our ﬁndings of higher copper in early pregnancy in women who sub-
sequently develop a pregnancy complication, which are similar to other
studies that have measured copper concentrations in late pregnancy
[15–17], suggest higher levels of circulating copper may contribute to
adverse pregnancy outcomes.
Of the three trace minerals, zinc in pregnancy has been most widely
studied. In human populations, zinc deﬁciency in pregnancy may be
associated with delivery of a low birthweight infant as well as with
hypertensive disorders of pregnancy, particularly in populations of
women vulnerable to inadequate zinc intakes in pregnancy [39].
However, inconsistencies between the studies on the eﬀect of zinc de-
ﬁciency in pregnancy reﬂects uncertainty within the literature. Fur-
thermore, the evidence with respect to the relationship between sele-
nium status and adverse pregnancy outcomes has not clearly been
established [40]. Never-the-less, our ﬁndings that lower levels of zinc
and selenium at 15 ± 1 weeks’ gestation is associated with a protec-
tive eﬀect on pregnancy outcome is in conﬂict with current dogma that
deﬁciencies in these nutrients are detrimental to pregnancy health.
However, given that both plasma zinc and selenium positively corre-
lated with plasma copper, and the protective eﬀect of lower plasma
copper persisted once plasma zinc and selenium were adjusted for,
implicates plasma copper status as the main contributor to adverse
pregnancy outcomes in this study. This is further supported by the
ﬁnding on combined copper and zinc status as whilst combined low
copper and low zinc was associated with reducing the risk of all preg-
nancy complications, equivalently, low copper and high zinc also ap-
peared to reduce the risk.
The greatest eﬀect observed in this study was in the association
between lower plasma copper in early pregnancy and the development
of any pregnancy complication. This suggests a role for this trace mi-
neral either within the causal pathway of, or as an early pregnancy
biomarker for, adverse pregnancy outcomes. PE, GDM, sPTB and SGA
are all often associated with placental dysfunction [41]. Pregnancies
complicated by placental dysfunction can be characterised by impaired
trophoblast invasion and transformation of the uterine spiral arteries
resulting in inadequate uteroplacental blood ﬂow or compromised fetal
placental vasculature development [42]. It is still unclear as to what
causes the initial failure of the placenta to form correctly. However, it is
likely to be a combination of both genetic and environmental factors
with increased oxidative and cellular stress, as well as inﬂammatory
mediators, thought to be key [43]. Elevated free copper can be a source
of oxidative stress [44] and thus, it is possible that elevated copper may
be a potential contributor to increased oxidative stress in the placenta,
particularly in early pregnancy.
Another potential hypothesis is that early pregnancy copper status
may be a biomarker for an increased inﬂammatory response which it-
self predisposes women to developing a pregnancy complication.
Pregnancy itself is considered a pro-inﬂammatory state, particularly
during the peri-implantation period [45]. However, even in pregnancy,
the inﬂammation response is tightly regulated and slight deviations can
result in compromised tissue function. Indeed, inﬂammation, as well as
obesity which induces persistent low-grade inﬂammation, are asso-
ciated with increasing the risk of a number of pregnancy complications
like PE and GDM [46–49]. However, we observed a protective eﬀect of
lower copper concentrations on the risk of pregnancy complications
after adjusting for BMI. Furthermore, in the sensitivity analysis, in
which all women with a possible infection or exacerbated inﬂammatory
response were excluded, very little change to the point estimates for
copper was found when compared to estimates calculated in the whole
cohort suggesting plasma copper is not necessarily just a biomarker for
inﬂammation.
The overall aim of this study was to determine whether early
pregnancy plasma trace mineral status was associated with pregnancy
complications. Despite the tight biological regulation of these minerals
in the circulation [50], lower levels of plasma copper, zinc and sele-
nium may be protective against a number of the major pregnancy
complications assessed. However, there are a number of limitations,
most notably lack of high quality dietary intake data, which may have
implications for the results of this study. Plasma and serum measures
are not generally considered accurate determinants of nutrient status
[51] and non-fasting blood samples were collected which is also likely
to have an eﬀect on short-term mineral status. Although, it is possible
that higher circulating levels of these trace elements represent reduced
bioavailability within cells, where the minerals are required. Hence, it
is conceivable that lower circulating levels of copper, zinc and selenium
may be associated with a reduced risk of pregnancy complications as
more of the trace elements are being utilised with tissues where re-
quired. Furthermore, given the lack of suitable alternatives in which to
determine women’s nutritional status in this pregnancy cohort, mea-
suring plasma minerals may still be informative in understanding the
physiology of pregnancy and pregnancy complications.
In conclusion, we observed a very clear association between plasma
copper concentrations in early pregnancy and the risk of pregnancy
complications that warrants further investigation particularly within
the context of other trace element status. It is conceivable that elevated
plasma copper status at the beginning of pregnancy may simply be a
biomarker of inﬂammation which may underlie the development of a
particular pregnancy complication. However, our data suggest it is
more likely to have a mechanistic role, potentially in the placenta
through oxidative stress or inﬂammatory pathways that warrants fur-
ther investigation. Much could be gained if we expand our under-
standing of maternal nutrition in pregnancy to incorporate simulta-
neous mechanistic and epidemiological studies, particularly on multiple
micronutrients and their interactions in order to fully elucidate the
importance of these factors in pregnancy success.
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